114 related articles for article (PubMed ID: 18803608)
1. The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2.
Stamnaes J; Fleckenstein B; Lund-Johansen F; Sollid LM
Scand J Immunol; 2008 Nov; 68(5):534-42. PubMed ID: 18803608
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages.
Hodrea J; Demény MA; Majai G; Sarang Z; Korponay-Szabó IR; Fésüs L
Immunol Lett; 2010 May; 130(1-2):74-81. PubMed ID: 20005901
[TBL] [Abstract][Full Text] [Related]
3. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
4. Characterizing monoclonal antibody epitopes by filtered gene fragment phage display.
Di Niro R; Ferrara F; Not T; Bradbury AR; Chirdo F; Marzari R; Sblattero D
Biochem J; 2005 Jun; 388(Pt 3):889-94. PubMed ID: 15720292
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites.
Mishra S; Murphy LJ
Biochem Biophys Res Commun; 2006 Sep; 347(4):1166-70. PubMed ID: 16870138
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies.
Caja S; Myrsky E; Korponay-Szabo IR; Nadalutti C; Sulic AM; Lavric M; Sblattero D; Marzari R; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Scand J Gastroenterol; 2010 Apr; 45(4):421-7. PubMed ID: 20095873
[TBL] [Abstract][Full Text] [Related]
7. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 12 in human ocular surface epithelia is the antigen reactive with a commercial anti-Galpha q antibody.
Boehlke CS; Yuan C; Kao WW; Huang AJ
Mol Vis; 2004 Nov; 10():867-73. PubMed ID: 15570220
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic response in mice expressing human autoantibodies.
Di Niro R; Sblattero D; Florian F; Stebel M; Zentilin L; Giacca M; Villanacci V; Galletti A; Not T; Ventura A; Marzari R
Mol Immunol; 2008 Mar; 45(6):1782-91. PubMed ID: 17996305
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
Chen X; Hnida K; Graewert MA; Andersen JT; Iversen R; Tuukkanen A; Svergun D; Sollid LM
J Biol Chem; 2015 Aug; 290(35):21365-75. PubMed ID: 26160175
[TBL] [Abstract][Full Text] [Related]
11. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
[TBL] [Abstract][Full Text] [Related]
12. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
[TBL] [Abstract][Full Text] [Related]
14. Identification of tissue transglutaminase as a novel molecule involved in human CD8+ T cell transendothelial migration.
Mohan K; Pinto D; Issekutz TB
J Immunol; 2003 Sep; 171(6):3179-86. PubMed ID: 12960346
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in celiac disease.
Alaedini A; Green PH
Autoimmunity; 2008 Feb; 41(1):19-26. PubMed ID: 18176861
[TBL] [Abstract][Full Text] [Related]
16. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
[TBL] [Abstract][Full Text] [Related]
17. Laminin binding protein, 34/67 laminin receptor, carries stage-specific embryonic antigen-4 epitope defined by monoclonal antibody Raft.2.
Katagiri YU; Kiyokawa N; Nakamura K; Takenouchi H; Taguchi T; Okita H; Umezawa A; Fujimoto J
Biochem Biophys Res Commun; 2005 Jul; 332(4):1004-11. PubMed ID: 15922307
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies with defined recognition sequences in the stem region of CD44: detection of differential glycosylation of CD44 between tumor and stromal cells in tissue.
Matsuki H; Yonezawa K; Obata K; Iwata K; Nakamura H; Okada Y; Seiki M
Cancer Res; 2003 Dec; 63(23):8278-83. PubMed ID: 14678986
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase and the stress response.
Ientile R; Caccamo D; Griffin M
Amino Acids; 2007 Aug; 33(2):385-94. PubMed ID: 17390097
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
Bodil Roth E; Theander E; Londos E; Sandberg-Wollheim M; Larsson A; Sjöberg K; Stenberg P
Scand J Immunol; 2008 Jun; 67(6):626-31. PubMed ID: 18476880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
